Schizophrenia is one kind of severe neuropsychiatric diseases which affect almost 1% of the world population. But the pathological mechanism...
Human health has been challenged by multidrug resistant microorganisms for several decades. Herein, we have developed a main-chain imidazoli...
Professor Chao He and his group firstly compared the secretome of fresh cultured CRC tumor tissues and paired normal colorectal (NC) tissues...
In postmortem brain material of preclinical Parkinson’s disease (PD), clinical PD, and control subjects, we determined with quantitati...
Epilepsy is a disabling neurological disorder that affects about 1% of the general population of all ages. About 30% of affected individuals...
ADP is a key platelet agonist responsible for platelet aggregation and thrombus stability in vivo. Our recent finding indicated that ADP sti...
Recently, the research of Chao He and his team from Sir Run Run Shaw Hospital, cooperated with Shanghai Jiaotong University, was published i...
The body's immune system relies on a spectrum of highly differentiated immune cells to combat external microbial infections. Among whi...
The Pictet−Spenglerase strictosidine synthase (STR1) has been recognized as a key enzyme in the biosynthesis of some 2000 indole alkal...
Bone marrow-derived mesenchymal stem cells (MSC) have been shown to home into tumor tissues, where they promote tumor growth and suppress im...
Bcr-Abl tyrosine kinase inhibitors (TKIs) have been a remarkable success for the treatment of Ph(+) chronic myeloid leukemia (CML). However,...
Speaker: Professor Sir Walter Bodmer
Speaker: Prof. Andries Kalsbeek, Netherlands Institute for Neuroscience
Title: Network and its promising approach for medical research
title:Cancer Genomic Revolution- Where are the new targets?